{
  "ticker": "TTX",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02963006",
  "id": "02963006",
  "pages": 18,
  "price_sensitive": false,
  "date": "20250627",
  "time": "1454",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250627/pdf/06l5z3n1mc8wg2.pdf",
  "summary": "### Summary of Tetratherix Limited ASX Listing Application  \n\n**Document Type**: Initial ASX Listing Application  \n\n#### **Key Material Information**:  \n- **Business Activity**: Development, manufacture, and sale of patented biomaterials (Australia-based).  \n- **Capital Structure**: Free float at listing will be \u226520% (per Prospectus Section 6.3).  \n- **Issue Price**: Securities priced at \u226520 cents (Prospectus Section 6.1).  \n- **Use of Proceeds**: Detailed in Prospectus Section 6.4 (no specific figures extracted here).  \n- **Governance Compliance**:  \n  - Constitution includes Appendix 15A provisions.  \n  - Audit and remuneration committees established (Prospectus Section 5.9).  \n- **Key Dates**:  \n  - Annual financial year end: 30 June.  \n  - AGM month: November.  \n- **Directors/Management**:  \n  - CEO: Will Knox (Australia-resident for 10+ years).  \n  - Proposed director Maurizio Vecchione (U.S. resident).  \n- **Material Contracts**: Disclosed in Prospectus Section 7 (no specifics provided here).  \n\n**No material trading or capital-raising timetable details identified** (further specifics would require Prospectus review).  \n\n**Note**: This is a compliance-oriented filing; material financials/offer details likely in the separate Prospectus (attachment 4).",
  "usage": {
    "prompt_tokens": 12469,
    "completion_tokens": 294,
    "total_tokens": 12763,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-27T05:16:34.260847"
}